Lightlake Therapeutics Inc. Receives Milestone Payment for U.S. Food and Drug Administration Approval of NARCAN(R) (Naloxone Hydrochloride) Nasal Spray
December 15, 2015 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
BioCorRx, Inc. Executes Letter of Intent to Sell Rights for the Start Fresh Program in Nevada
May 08, 2014 08:00 ET
|
BioCorRx
Los Angeles, May 8, 2014 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB:
BICX), a leader in addiction treatment and rehabilitation programs,
announced it has entered into a letter of intent to sell...
Leading National Pain and Addiction Treatment Specialist Comments on CDC Report
July 05, 2013 12:41 ET
|
Father Martin's Ashley
HAVRE DE GRACE, MD--(Marketwired - Jul 5, 2013) - The Center for Disease Control and Prevention (CDC) yesterday reported that painkiller overdose deaths among women are up 400 percent over the last...